Stephens Inc Precigen, Inc. Transaction History

Stephens Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$1.15 - $2.53 $12,379 - $27,235	-10,765 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$1.91 - $3.98 $14,609 - $30,443	-7,649 Reduced 41.54%	10,765 $23,000
Q4 2021 Mar 07, 2022	SELL	$3.53 - $5.5 $3,530 - $5,500	-1,000 Reduced 5.15%	18,414 $68,000
Q2 2021 Aug 12, 2021	BUY	$6.24 - $8.22 $32,859 - $43,286	5,266 Added 37.22%	19,414 $127,000
Q1 2021 May 14, 2021	BUY	$6.74 - $10.95 $6,740 - $10,950	1,000 Added 7.61%	14,148 $97,000
Q4 2020 Feb 10, 2021	SELL	$3.75 - $10.56 $3,750 - $10,560	-1,000 Reduced 7.07%	13,148 $134,000
Q3 2020 Nov 13, 2020	SELL	$3.5 - $6.2 $458 - $812	-131 Reduced 0.92%	14,148 $50,000
Q2 2020 Aug 24, 2020	SELL	$2.16 - $5.46 $31,320 - $79,170	-14,500 Reduced 50.38%	14,279 $71,000
Q1 2020 May 14, 2020	BUY	$1.46 - $7.19 $42,017 - $206,921	28,779 New	28,779 $98,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $158M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.